Autolus Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on March 10
Autolus Therapeutics plc (Nasdaq: AUTL) will announce its fourth quarter and full year 2021 financial results and operational highlights on March 10, 2022, before U.S. market open. The management team will host a conference call at 8:30 am ET to discuss the results and provide a business update. Interested parties can access the call via webcast, with a replay available for one week afterward. This event marks a critical opportunity for investors to evaluate the company’s performance in the clinical-stage biopharmaceutical sector focused on T cell therapies.
- None.
- None.
LONDON, Feb. 21, 2022 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its fourth quarter and full year 2021 financial results and operational highlights before open of U.S. markets on Thursday, March 10, 2022.
Management will host a conference call and webcast at 8:30 am ET/1:30 pm GMT to discuss the company’s financial results and provide a general business update. To listen to the webcast and view the accompanying slide presentation, please go to the events section of Autolus’ website
The call may also be accessed by dialing (866) 679-5407 for U.S. and Canada callers or (409) 217-8320 for international callers. Please reference conference ID 2794888. After the conference call, a replay will be available for one week. To access the replay, please dial (855) 859-2056 for U.S. and Canada callers or (404) 537-3406 for international callers. Please reference conference ID 2794888.
Contact:
Julia Wilson
+44 (0) 7818 430877
j.wilson@autolus.com
Susan A. Noonan
S.A. Noonan Communications
+1-212-966-3650
susan@sanoonan.com
FAQ
When will Autolus Therapeutics release its Q4 and full year 2021 financial results?
What time is the Autolus Therapeutics conference call scheduled?
How can I access the Autolus Therapeutics financial results webcast?